DprE1-IN-8

• Description:

  DprE1-IN-8 is a potent DprE1 inhibitor with an IC50 value of IC50 of 6 nM and can be used for tuberculosis research[1].

• UNSPSC:

  12352005

• Target:

  Antibiotic; Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/dpre1-in-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN(C1=NC(C2=CC(C(F)(F)F)=CC([N+]([O-])=O)=C2S1)=O)CC3=NN=C(O3)C4=CC=CC=C4

• Molecular Formula:

  C19H12F3N5O4S

• Molecular Weight:

  463.39

• References & Citations:

  [1]Dongguang Fan, et al. Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity. Biomedicines. 2023 Jul 12;11 (7) :1975.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2679830-77-2]